Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 19,6x - 21,7x | 20,7x |
| Selected Fwd EBIT Multiple | 5,6x - 6,2x | 5,9x |
| Fair Value | ₹421,74 - ₹466,16 | ₹443,95 |
| Upside | 31,8% - 45,6% | 38,7% |
| Benchmarks | Ticker | Full Ticker |
| Maitreya Medicare Limited | MAITREYA | NSEI:MAITREYA |
| Novelix Pharmaceuticals Limited | 536565 | BSE:536565 |
| Krsnaa Diagnostics Limited | 543328 | BSE:543328 |
| Indraprastha Medical Corporation Limited | 532150 | BSE:532150 |
| Shalby Limited | 540797 | BSE:540797 |
| One Global Service Provider Limited | 514330 | BSE:514330 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| MAITREYA | 536565 | 543328 | 532150 | 540797 | 514330 | ||
| NSEI:MAITREYA | BSE:536565 | BSE:543328 | BSE:532150 | BSE:540797 | BSE:514330 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | NM- | 16.6% | 24.1% | 20.9% | 104.2% | |
| 3Y CAGR | -7.9% | NM- | 7.0% | 172.2% | 35.4% | 58.9% | |
| Latest Twelve Months | NM | NM | 48.8% | 35.7% | -24.5% | 234.4% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 11.2% | -10.3% | 14.1% | 8.6% | 10.8% | -2154.3% | |
| Prior Fiscal Year | 16.2% | -3.0% | 14.2% | 10.2% | 11.5% | 7.5% | |
| Latest Fiscal Year | 10.5% | -0.3% | 11.2% | 12.4% | 13.8% | 15.1% | |
| Latest Twelve Months | 7.6% | 1.4% | 13.8% | 14.1% | 8.4% | 17.0% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 4.49x | 2.45x | 3.81x | 2.72x | 2.29x | 2.51x | |
| EV / LTM EBITDA | 43.6x | 148.0x | 15.3x | 16.1x | 18.4x | 14.6x | |
| EV / LTM EBIT | 59.4x | 171.7x | 27.6x | 19.2x | 27.3x | 14.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 19.2x | 27.6x | 171.7x | ||||
| Historical EV / LTM EBIT | 3.9x | 13.3x | 20.8x | ||||
| Selected EV / LTM EBIT | 19.6x | 20.7x | 21.7x | ||||
| (x) LTM EBIT | 154 | 154 | 154 | ||||
| (=) Implied Enterprise Value | 3,030 | 3,189 | 3,349 | ||||
| (-) Non-shareholder Claims * | (2) | (2) | (2) | ||||
| (=) Equity Value | 3,028 | 3,187 | 3,347 | ||||
| (/) Shares Outstanding | 7.1 | 7.1 | 7.1 | ||||
| Implied Value Range | 426.16 | 448.60 | 471.04 | ||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 426.16 | 448.60 | 471.04 | 320.10 | |||
| Upside / (Downside) | 33.1% | 40.1% | 47.2% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | MAITREYA | 536565 | 543328 | 532150 | 540797 | 514330 | |
| Enterprise Value | 2,125 | 265 | 26,475 | 36,145 | 24,602 | 2,276 | |
| (+) Cash & Short Term Investments | 82 | 2 | 626 | 3,094 | 1,486 | 1 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (57) | 0 | (2,161) | (327) | (4,633) | (3) | |
| (-) Other Liabilities | (9) | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 2,141 | 266 | 24,941 | 38,911 | 21,456 | 2,274 | |
| (/) Shares Outstanding | 6.8 | 10.0 | 32.3 | 91.7 | 107.4 | 7.1 | |
| Implied Stock Price | 316.00 | 26.61 | 772.40 | 424.45 | 199.75 | 320.10 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 316.00 | 26.61 | 772.40 | 424.45 | 199.75 | 320.10 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |